Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years.

Autor: Berning P; Department of Hematology and Oncology, University Hospital Muenster, Muenster, Germany., Fekom M; European Society for Blood and Marrow Transplantation, Paris, France., Ngoya M; European Society for Blood and Marrow Transplantation, Paris, France., Goldstone AH; HCA Healthcare, Macmillan Cancer Centre, London, United Kingdom., Dreger P; Department of Medicine V, University of Heidelberg, Heidelberg, Germany., Montoto S; St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Finel H; European Society for Blood and Marrow Transplantation, Paris, France., Shumilov E; Department of Hematology and Oncology, University Hospital Muenster, Muenster, Germany., Chevallier P; Department of Hematology, CHU Nantes, Nantes, France., Blaise D; Transplantation and Cellular Immunotherapy Program, Department of Hematology, Instititut Paoli Calmettes, MSC Lab, Aix Marseille University, Marseille, France., Strüssmann T; Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany., Carpenter B; Department of Hematology, University College London Hospitals, London, United Kingdom., Forcade E; Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, F-33000, Bordeaux, France., Castilla-Llorente C; Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France., Trneny M; First Faculty of Medicine, Charles University, Praha, Czech Republic., Ghesquieres H; Hospices Civils de Lyon, Hôpital Lyon Sud, Service d'Hématologie, Pierre Bénite, France., Capria S; Department of Translational and Precision Medicine, Policlinico Umberto I Hospital, Sapienza University of Rome, Rome, Italy., Thieblemont C; Department of Hemato-Oncology, Hôpital Saint-Louis APHP, Paris, France., Blau IW; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität Berlin, Department of Hematology, Oncology and Tumor Immunology, Campus Virchow Clinic, Berlin, Germany., Meijer E; Department of Hematology, Amsterdam University Medical Center, Free University, Amsterdam, the Netherlands., Broers AEC; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Huynh A; CHU - Institut Universitaire du Cancer Toulouse, Oncopole, I.U.C.T-O, Toulouse, France., Caillot D; Department of Hematology, CHU Dijon, Dijon, France., Rösler W; Department of Internal Medicine 5, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany., Nguyen Quoc S; Department of Hematology, AP-HP, Sorbonne Université, Pitié- Salpêtrière Hospital, Paris, France., Bittenbring J; Department of Hematology and Oncology, Saarland University Medical School, Homburg, Germany., Nagler A; Division of Hematology, Sheba Medical Center, Tel Hashomer, Israel., Galimard JE; European Society for Blood and Marrow Transplantation, Paris, France., Glass B; Department of Hematology, Oncology, Tumor Immunology, and Palliative Care, Helios Klinikum Berlin-Buch, Berlin, Germany., Sureda A; Department of Hematology, Institut Català d'Oncologia Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Schmitz N; Department of Hematology and Oncology, University Hospital Muenster, Muenster, Germany. norbert.schmitz@ukmuenster.de.

Publikováno v: Blood cancer journal [Blood Cancer J] 2024 Jul 05; Vol. 14 (1), pp. 106. Date of Electronic Publication: 2024 Jul 05.

A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab- ozogamicin.

Autor: Strüßmann, T.¹ (AUTHOR), Wäsch, R.¹ (AUTHOR), Scherer, F.^1,2 (AUTHOR), Mutter, J. A.^1,3 (AUTHOR), Pfeifer, D.¹ (AUTHOR), Bartsch, I.¹ (AUTHOR), Giesler, S.¹ (AUTHOR), Graziani, G.¹ (AUTHOR), Duyster, J.¹ (AUTHOR), Finke, J.¹ (AUTHOR), Marks, R.¹ (AUTHOR)

Publikováno v: Leukemia & Lymphoma. Sep2022, Vol. 63 Issue 9, p2260-2262. 3p.

Dosage of high-dose methotrexate as CNS prophylaxis in DLBCL: A detailed analysis of toxicity and impact on CNS relapse.

Autor: Wilson MR; Beatson West of Scotland Cancer Centre, Glasgow, UK., Kirkwood AA; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK., Wong Doo N; Concord Clinical School, Concord Hospital University of Sydney, Sydney, Australia., Soussain C; Institut Curie Hôpital René Huguenin, Saint-Cloud, France., Choquet S; La Pitie Salpetriere Hospital, APHP-Sorbonne Universite, Paris, France., Lees C; Oxford University Hospitals NHS Trust, Churchill Cancer Center, Oxford, UK., Fox C; Nottingham University Hospitals NHS Trust, Nottingham, UK., Preston G; Aberdeen Royal Infirmary, Aberdeen, UK., Ahearne M; University Hospitals of Leicester NHS Trust, Leicester, UK., Strüßmann T; University Medical Center Freiburg, Freiburg, Germany., Clavert A; Service des Maladies du Sang, CHU Angers, Angers, France., Rusconi C; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ku M; St Vincent's Hospital Melbourne, Melbourne, Australia., Khwaja J; University College London Hospitals NHS Foundation Trust, London, UK., Narkhede M; University of Alabama, Birmingham, Alabama, USA., Lewis K; Linear Clinical Research and Sir Charles Gairdner Hospital, Nedlands, WA, Australia., Durot E; Hôpital Robert Debré CHU de Reims, Reims, France., Smith J; Liverpool University Hospitals Foundation Trust, Liverpool, UK., Renaud L; Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Ferreri AJM; IRCCS San Raffaele Scientific Institute, Milano, Italy., El-Galaly T; Aalborg University Hospital, Aalborg, Denmark., Cwynarski K; University College London Hospitals NHS Foundation Trust, London, UK., McKay P; Beatson West of Scotland Cancer Centre, Glasgow, UK., Eyre TA; Oxford University Hospitals NHS Trust, Churchill Cancer Center, Oxford, UK.

Publikováno v: American journal of hematology [Am J Hematol] 2024 Feb; Vol. 99 (2), pp. E46-E50. Date of Electronic Publication: 2023 Nov 30.

Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab.

Autor: Strüßmann T; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany. tim.struessmann@uniklinik-freiburg.de., Jung J; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany., Heinz J; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany., Duque Afonso J; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany., Wäsch R; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany., Engelhardt M; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany., Duyster J; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany., Finke J; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany., Marks R; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany.

Publikováno v: Annals of hematology [Ann Hematol] 2023 Jan; Vol. 102 (1), pp. 245-247. Date of Electronic Publication: 2022 Nov 17.